Pure Global

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX - Trial NCT06010524

Access comprehensive clinical trial information for NCT06010524 through Pure Global AI's free database. This phase not specified trial is sponsored by Cerrahpasa Medical Faculty Foundation and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 450 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06010524
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06010524
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX
A Retrospective Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX: Real Life Study

Study Focus

Hepatitis C

Observational

Sponsor & Location

Cerrahpasa Medical Faculty Foundation

Istanbul, Turkey

Timeline & Enrollment

N/A

Feb 01, 2023

Dec 31, 2023

450 participants

Primary Outcome

Sustained Virology Response 12

Summary

This is a retrospective, non-interventional study. Investigators from infectious diseases and
 gastroenterology departments will participate this study.
 
 Patients data will be collected from hospital medical records.

ICD-10 Classifications

Acute hepatitis C
Chronic viral hepatitis C
Viral hepatitis
Chronic viral hepatitis
Unspecified viral hepatitis

Data Source

ClinicalTrials.gov

NCT06010524

Non-Device Trial